Related references
Note: Only part of the references are listed.Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy
Kerstin Hellwig et al.
JAMA NETWORK OPEN (2022)
Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis
Sarah Demortiere et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
Marinella Clerico et al.
NEUROTHERAPEUTICS (2020)
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project
Joan K. Morris et al.
JOURNAL OF NEUROLOGY (2020)
Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use
James D. Triplett et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab-A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry
Michael Guger et al.
FRONTIERS IN NEUROLOGY (2020)
Exposure to natalizumab during pregnancy and lactation is safe - Yes
Doriana Landi et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab
Neda Razaz et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study
Maria C. Magnus et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosing
John F. Foley et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Navigating monoclonal antibody use in breastfeeding women Do no harm or do little good?
Sara C. LaHue et al.
NEUROLOGY (2019)
Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review
Anjiao Peng et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines
Ruth Dobson et al.
PRACTICAL NEUROLOGY (2019)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks
Emilio Portaccio et al.
NEUROLOGY (2018)
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks
Emilio Portaccio et al.
NEUROLOGY (2018)
Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients
Tatiana Plavina et al.
NEUROLOGY (2017)
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis
Sandra Vukusic et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Predictors and dynamics of postpartum relapses in women with multiple sclerosis
Stella E. Hughes et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Natalizumab Use During the Third trimester of Pregnancy
Aiden Haghikia et al.
JAMA NEUROLOGY (2014)
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany
Kerstin Hellwig et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Breastfeeding is not related to postpartum relapses in multiple sclerosis
E. Portaccio et al.
NEUROLOGY (2011)
The relapse rate of multiple sclerosis changes during pregnancy: a cohort study
G Salemi et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Share Paper
